CTOs on the Move

Medstreaming

www.medstreaming.com

 
Headquartered in Redmond, WA, Medstreaming is a leading provider of Healthcare IT (“HCIT”) solutions for image intensive specialties. We are focused on enabling proactive patient care and increasing the efficiency of healthcare by providing medical IT solutions to individual practitioners and large institutions alike. Since its founding in 2006, Medstreaming has become a market leader in delivering specialty-based workflow applications that function as a “best of breed” specialties, including, but not limited to, Cardiology, Vascular, Vein & Surgery. Lead by a team of founding engineers, clinical specialists, and healthcare IT veterans, Medstreaming is committed to dramatically improving the delivery of healthcare ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Guidry and East

Guidry and East is a League City, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CardioMag Imaging

CardioMag Imaging, Inc. (CMI) is a privately held medical device company founded in 1999 and is engaged in the development and commercialization of a unique kind of cardiac diagnostic device known as MagnetoCardioGraphs (MCG). The device the company has

PT Group the

PT Group the is a New Kensington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Primus Sterilizer

Primus Sterilizer is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.